Table 1.
Summary of patients characteristics at treatment start.
| Number of patients | 45 | |
|---|---|---|
|
Age [years] (median and range) |
72 [57-81] | |
| Stage T | T1c | 22 (49%) |
| T2a-c | 17 (38%) | |
| T3a-b | 6 (13%) | |
| Stage N | N0 | 43 (96%) |
| N1 | 1 (2%) | |
| Nx | 1 (2%) | |
| Stage M | M0 | 45 (100%) |
| M1 | 0 (0%) | |
| Gleason score | 6 | 25 (56%) |
| 7 | 20 (44%) | |
|
PSA at staging (μg/l) (Median and range) |
10.0 [4.7, 33.8] | |
| Hormonotherapy | Yes | 31 (69%) |
| No | 14 (31%) | |
| Surgery | Yes | 2 (4%) |
| No | 43 (96%) | |
| Dose Prescription: | ||
| Group A | 70+6 Gy | 7 (16%) |
| 70+8 Gy | 9 (20%) | |
| Group B | 78 Gy | 29 (64%) |